These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28446169)

  • 1. The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England.
    Donker T; Henderson KL; Hopkins KL; Dodgson AR; Thomas S; Crook DW; Peto TEA; Johnson AP; Woodford N; Walker AS; Robotham JV
    BMC Med; 2017 Apr; 15(1):86. PubMed ID: 28446169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-based evaluation of admission screening strategies for the detection and control of carbapenemase-producing Enterobacterales in the English hospital setting.
    Pople D; Kypraios T; Donker T; Stoesser N; Seale AC; George R; Dodgson A; Freeman R; Hope R; Walker AS; Hopkins S; Robotham J
    BMC Med; 2023 Dec; 21(1):492. PubMed ID: 38087343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.
    Trepanier P; Mallard K; Meunier D; Pike R; Brown D; Ashby JP; Donaldson H; Awad-El-Kariem FM; Balakrishnan I; Cubbon M; Chadwick PR; Doughton M; Doughton R; Hardiman F; Harvey G; Horner C; Lee J; Lewis J; Loughrey A; Manuel R; Parsons H; Perry JD; Vanstone G; White G; Shetty N; Coia J; Wiuff C; Hopkins KL; Woodford N
    J Antimicrob Chemother; 2017 Feb; 72(2):596-603. PubMed ID: 27687074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation.
    Schneider A; Coope C; Michie S; Puleston R; Hopkins S; Oliver I
    BMC Health Serv Res; 2019 Oct; 19(1):689. PubMed ID: 31606053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission.
    Mookerjee S; Dyakova E; Davies F; Bamford K; Brannigan ET; Holmes A; Otter JA
    J Hosp Infect; 2018 Sep; 100(1):15-20. PubMed ID: 29883616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization.
    Poole K; George R; Decraene V; Shankar K; Cawthorne J; Savage N; Welfare W; Dodgson A
    J Hosp Infect; 2016 Oct; 94(2):125-9. PubMed ID: 27542962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probabilistic microsimulation to examine the cost-effectiveness of hospital admission screening strategies for carbapenemase-producing enterobacteriaceae (CPE) in the United Kingdom.
    Manoukian S; Stewart S; Dancer SJ; Mason H; Graves N; Robertson C; Leonard A; Kennedy S; Kavanagh K; Parcell B; Reilly J
    Eur J Health Econ; 2022 Sep; 23(7):1173-1185. PubMed ID: 34932169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012.
    Fournier S; Monteil C; Lepainteur M; Richard C; Brun-Buisson C; Jarlier V; Ap-Hp Outbreaks Control Group C
    Euro Surveill; 2014 May; 19(19):. PubMed ID: 24852956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
    Albiger B; Glasner C; Struelens MJ; Grundmann H; Monnet DL;
    Euro Surveill; 2015; 20(45):. PubMed ID: 26675038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acceptability of screening for Carbapenemase Producing
    Currie K; King C; McAloney-Kocaman K; Roberts NJ; MacDonald J; Dickson A; Cairns S; Khanna N; Flowers P; Reilly J; Price L
    Antimicrob Resist Infect Control; 2018; 7():144. PubMed ID: 30534365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of a toolkit for the early detection, management, and control of carbapenemase-producing Enterobacteriaceae: a survey of acute hospital trusts in England.
    Coope CM; Verlander NQ; Schneider A; Hopkins S; Welfare W; Johnson AP; Patel B; Oliver I
    J Hosp Infect; 2018 Aug; 99(4):381-389. PubMed ID: 29530741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
    Huang TD; Bogaerts P; Berhin C; Hoebeke M; Bauraing C; Glupczynski Y;
    Euro Surveill; 2017 May; 22(19):. PubMed ID: 28537547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient experience of hospital screening for carbapenemase-producing Enterobacteriaceae: A qualitative study.
    King C; Grandison T; Cawthorne J; Currie K
    J Clin Nurs; 2019 Nov; 28(21-22):3890-3900. PubMed ID: 31240778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues].
    Lepelletier D; Batard E; Berthelot P; Zahar JR; Lucet JC; Fournier S; Jarlier V; Grandbastien B
    Rev Med Interne; 2015 Jul; 36(7):474-9. PubMed ID: 25600328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the role of inter-facility patient transfer in the spread of carbapenemase-producing Enterobacteriaceae: the case of France between 2012 and 2015.
    Nekkab N; Crépey P; Astagneau P; Opatowski L; Temime L
    Sci Rep; 2020 Sep; 10(1):14910. PubMed ID: 32913244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014.
    Samuelsen Ø; Overballe-Petersen S; Bjørnholt JV; Brisse S; Doumith M; Woodford N; Hopkins KL; Aasnæs B; Haldorsen B; Sundsfjord A;
    PLoS One; 2017; 12(11):e0187832. PubMed ID: 29141051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
    J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.
    Otter JA; Dyakova E; Bisnauthsing KN; Querol-Rubiera A; Patel A; Ahanonu C; Tosas Auguet O; Edgeworth JD; Goldenberg SD
    J Antimicrob Chemother; 2016 Dec; 71(12):3556-3561. PubMed ID: 27516471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of screening methods, rates and policies for the detection of carbapenemase-producing Enterobacteriaceae in English hospitals.
    Berry C; Davies K; Woodford N; Wilcox M; Chilton C
    J Hosp Infect; 2019 Feb; 101(2):158-162. PubMed ID: 30092291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.